Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-104776
Filing Date
2020-04-13
Accepted
2020-04-13 07:03:35
Documents
2
Effectiveness Date
2020-04-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A d917452ddefa14a.htm DEFA14A 93111
2 GRAPHIC g917452g26h80.gif GRAPHIC 1314
  Complete submission text file 0001193125-20-104776.txt   95951
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

EIN.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37702 | Film No.: 20787782
SIC: 2836 Biological Products, (No Diagnostic Substances)